tofacitinib,ustekinumab
janssen,pfizer
['tofa', 'tofacitinib', ' uc ', 'ustekinumab']
 presenting at #acg2022. uc patients who do not respond to anti-tnf and then get tofacitinib or ustekinumab after adjustment for confounding, no significant differences in steroid free clinical remission at 12 or 52 weeks or drug survival between tofa and uste. 
IBD specialist, Educator & GI Fellowship Program Director @ClevelandClinic| Board of Trustees @AmCollegeGastro| Cleveland sports fan| T/RT = my own